Cocoon

Duct Occluder

KEY HIGHLIGHTS

  1. Hat shaped tapered design ensures secired implantation at aorta and minimizes risk of mirgration in pulmonary artey

  2. Device is filled with polyester fabric to assist thrombogenicity

  3. Extended retention portion provides proper positioning of the device in ductus arteriosus 

  4. 100% occlusion rate at one month follow up

  5. Ability to recapture and redeploy

4-min

The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.

3-min

The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.

Cocoon

VSD Occluders

KEY HIGHLIGHTS

  1. Self- expanding, Double disc device with unique Platinum coating

  2. 4,7& 10 mm waist length available

  3. Available in multiple length to match the types and location of ventricular septal defects to close membranous and muscular defects 

  4. Discs are filled with polypropylene fabric which assists thrombogenicity

  5. Ability to recapture and redeploy

Cocoon

Septal Occluder

KEY HIGHLIGHTS

  1. Self-expanding, self -centering double disc device with unique platinum cocated nitinol wire mesh

  2. Both discs are connected by a waist at the center

  3. Discs are filled with polypropylene fabric which assists thrombogenicity

  4. 95 to 100% Device sucess rate from early Europeans experience

  5. Ability to recapture and redeploy
  6. 0% Erosion up to 43 months of follow up in more than 4000 patients

0-min (1)

The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.

20-min

The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.

Cocoon

Septal Occluder

No Compromise

KEY HIGHLIGHTS

  1. Self-expanding, self -centering double disc device with unique platinum coating

  2. Discs are filled with polypropylene fabric which assists thrombogenicity

  3. 95 to 100% Device sucess rate from early Europeans experience

  4. Ability to recapture and redeploy
  5. 0% Erosion up to 43 months of follow up in more than 4000 patients